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Abstract
Background: Reporting of adverse events in randomized clinical trials (RCTs) is encouraged by the authors of The
Consolidated Standards of Reporting Trials (CONSORT) statement. With robust methodological design and adequate
reporting, RCTs have the potential to provide useful evidence on the incidence of adverse events associated with
spinal manipulative therapy (SMT). During a previous investigation, it became apparent that comprehensive search
strategies combining text words with indexing terms was not sufficiently sensitive for retrieving records that were
known to contain reports on adverse events. The aim of this analysis was to compare the proportion of articles
containing data on adverse events associated with SMT that were indexed in MEDLINE and/or EMBASE and the
proportion of those that included adverse event-related words in their title or abstract.
Methods: A sample of 140 RCT articles previously identified as containing data on adverse events associated with
SMT was used. Articles were checked to determine if: (1) they had been indexed with relevant terms describing
adverse events in the MEDLINE and EMBASE databases; and (2) they mentioned adverse events (or any related terms)
in the title or abstract.
Results: Of the 140 papers, 91% were MEDLINE records, 85% were EMBASE records, 81% were found in both
MEDLINE and EMBASE records, and 4% were not in either database. Only 19% mentioned adverse event-related
text words in the title or abstract. There was no significant difference between MEDLINE and EMBASE records in
the proportion of available papers (p = 0.078). Of the 113 papers that were found in both MEDLINE and EMBASE
records, only 3% had adverse event-related indexing terms assigned to them in both databases, while 81% were
not assigned an adverse event-related indexing term in either database.
Conclusions: While there was effective indexing of RCTs involving SMT in the MEDLINE and EMBASE databases, there
was a failure of allocation of adverse event indexing terms in both databases. We recommend the development of
standardized definitions and reporting tools for adverse events associated with SMT. Adequate reporting of adverse
events associated with SMT will facilitate accurate indexing of these types of manuscripts in the databases.
Keywords: Indexing, Adverse events, Harms, Spinal manipulative therapy, Literature review
* Correspondence: lindsay.gorrell@ucalgary.ca
1Human Performance Laboratory, KNB 222, Faculty of Kinesiology, University
of Calgary, Calgary, Alberta T2N 1 N4, Canada
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gorrell et al. BMC Medical Research Methodology  (2017) 17:41 
DOI 10.1186/s12874-017-0320-x
Background
The purpose of a randomized clinical trial (RCT) is to
collect and appropriately report both beneficial and
harmful effects from an intervention and to compare
these outcomes across groups. However, it is far more
common for RCTs and in turn, systematic reviews, to
focus on the beneficial effects of an intervention ver-
sus harms data when reporting results [1]. Recognition
of this inequality in reporting is important as it may
bias the ability of both health-care practitioners and
patients to accurately assess the risk-benefit ratio of
an intervention.
Adverse events which have been associated with spinal
manipulative therapy (SMT) range from catastrophic,
such as cervical artery dissection resulting in stroke to
mild, transient muscle soreness or stiffness [2–4]. Typic-
ally, catastrophic events are rare while minor events are
more common and are considered by some authors to
be an expected treatment outcome [4, 5]. While main-
taining a focus on catastrophic events is understandable
[6–8], quantifying the incidence of other types of adverse
events associated with SMT is also necessary in order to
accurately inform prognoses, and management decisions
[5, 9, 10]. Although previous reports on the incidence of
minor and moderate adverse events following manual
therapy [5] are welcome, their conclusions are limited as
they were based on a small number of trials and it is not
clear exactly how representative these reports are of the
incidence of mild and moderate adverse events specific-
ally associated with SMT [5, 11].
Adequate reporting of adverse events in RCTs is en-
couraged by the authors of The Consolidated Standards
of Reporting Trials (CONSORT) statement which was
first published in 1996 and subsequently updated in
2001 and 2010 respectively [12–14]. Furthermore, in
2004 an extension to the statement was published which
attempted to directly address the reporting of adverse
events. Specifically, this extension discussed the inad-
equacy of current adverse events reporting and provided
10 recommendations for reporting which were later
adopted in the 2010 version of the statement [15]. With
robust methodological design and adequate reporting,
RCTs, in conjunction with case reports and observa-
tional studies, have the potential to provide useful evi-
dence on the incidence of adverse events associated with
SMT. Comprehensive reporting of adverse events (and
exposures) across multiple trials could allow for pooled
analyses over time and may provide a way of estimating
the incidence rates for all classifications (minor – cata-
strophic) of adverse events thereby helping to inform
management strategies.
During a previous investigation into the reporting of
adverse events associated with SMT, it became apparent
that comprehensive search strategies combining text
words (e.g., “spinal manipulation” or “spinal manipula-
tive therapy”) with indexing terms (e.g., “adverse event”
or “adverse effect”) were not sufficiently sensitive for
retrieving records that were known to contain reports
on adverse events [16]. This observation was based on
recent searches of the Central Register of Controlled
Trials (CENTRAL) and Physiotherapy Evidence Data-
base (PEDro) which index approximately 97% and
95% of all RCTs involving manual therapy respect-
ively [17, 18].
Our primary objectives, therefore, were: (1) to deter-
mine the completeness of assignment of adverse event-
related indexing terms in MEDLINE and EMBASE re-
cords of a pool of papers known to report on adverse
events following SMT; (2) to compare the completeness
of assignment of adverse event-related indexing terms in
MEDLINE and EMBASE records; and (3) to determine
the proportion of papers in which SMT was an interven-
tion that included adverse event-related words in their
title or abstract. While similar investigations have been
performed to assess the adequacy of adverse event
reporting in the literature relating to pharmaceutical [1, 19]
and physiotherapy interventions [17], this is the first study
to investigate the completeness of adverse event indexing
in RCTs involving SMT.
Methods
We used a reference sample of 140 RCT articles previ-
ously identified as containing data on adverse events
associated with SMT [16]. These articles were identified
using a comprehensive search that included electronic
searching of PEDro and Cochrane CENTRAL from in-
ception to February 2016 and subsequent snowballing
strategies. See Appendix 1 for the complete search
strategy for the Cochrane CENTRAL database.
Each article in the reference sample was manually
checked to determine if: (1) it had been indexed with
relevant terms describing adverse events in the MEDLINE
and EMBASE databases; and (2) it mentioned adverse
events (or any related terms) in the title or abstract (thus
enabling the paper to be found in an electronic search
using text words).
Brief overview of EMBASE and MEDLINE indexing
processes
For articles published in English, the indexing in
EMBASE follows the Elsevier Life Science Thesaurus –
Emtree. This thesaurus contains over 70,000 biomedical
preferred terms and 290,000 synonyms that are ordered
within 14 facets e.g., healthcare concepts. For the most
part, indexing terms are manually chosen based on the
full-text content of an article. This process is carried out
by trained indexers with a biomedical background ac-
cording to well-defined guidelines that are subject to
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regular quality assurance checks. The relevant concepts
within an article are identified and matched with specific
Emtree terms. Each indexing term is designated as either
a major or minor term based on relevance to the con-
cepts presented within each article. Articles are indexed
with an average of 3–4 major terms and several minor
terms, with major terms being weighted more heavily than
the minor with regard to relevance during a search. With
regards to harms- related indexing terms in EMBASE, the
indexing framework has been built primarily around drug
therapy with common terms including side effect, and
adverse drug reaction. All adverse events/effects are
indexed with the term side effect with no consideration given
to the severity of the adverse event/effect. Terms that are
not currently indexed on Emtree are indexed as candidate
terms. These candidate terms are evaluated regularly for
possible inclusion on the Emtree thesaurus [20].
The indexing process is similar in MEDLINE. Indexers
screen the title, abstract, body and bibliography of the
article for relevant concepts and compare these with the
keywords suggested by the author/publisher. The in-
dexers then use the National Library of Medicine MeSH
Browser to find indexing terms (major and non-major)
that most accurately match the concept being indexed
from the Medical Subject Heading (MeSH) thesaurus
[21]. The MeSH vocabulary is continually revised and
updated based on suggestions from indexers, and con-
sultation with professionals from various disciplines with
specialized vocabularies [22]. The headings relating to
harms in the MeSH database include the following:
patient harm, drug-related side effects and adverse
reactions, drug eruptions, iatrogenic disease, and long
term adverse effects [23].
Details of papers included in the review
Spinal manipulative therapy was defined as manual ther-
apy involving a high-velocity, low amplitude manipula-
tion directed at a spinal joint with the intention of
moving the joint past its physiological range of motion
without exceeding the anatomical limit [24, 25]. Spinal
manipulation delivered using mechanical instruments
and drop-table mechanisms were also included in this
review as they have been classified as high-velocity, low
amplitude procedures in the literature [24, 26].
Randomized clinical trials that reported original data
from SMT, either as the sole intervention or as part of a
multi-modal intervention, delivered by a regulated man-
ual therapy practitioner were eligible for inclusion. We
excluded manuscripts reporting all other trial designs,
commentaries, editorials, reviews, trial registrations and
protocols, conference proceedings, full text articles not
available in English, articles that had been retracted, sec-
ondary analyses, articles reporting on interventions that
were applied to regions other than the spine, if the
intervention was self-administered (e.g., exercise), and
finally if it was unclear whether or not the SMT applied
was high-velocity and low amplitude in nature. The
eligibility criteria were applied at each stage of the selec-
tion process. An assessment of the risk of bias was per-
formed for all included articles using the Cochrane risk
of bias assessment tool [27].
Data analysis
The completeness of records in MEDLINE and EMBASE
was determined by calculating proportions, which were
subsequently compared using an exact McNemar test
with a significance level set at 0.05. The completeness of
assignment of adverse event-related indexing terms to
database records and comparison of proportions were de-
termined in the same manner. The proportion of papers
using adverse event-related indexing terms in the title or
abstract was calculated, and the frequencies of adverse
event-related indexing terms used in titles or abstracts,
MEDLINE records, and EMBASE records were collated
separately. All analyses were conducted using the statis-
tical software package R, version 3.3.1 (R Core Team,
Vienna, Austria).
Results
Of the total pool of 140 papers, 128 (91%) and 119
(85%) papers had records in MEDLINE and EMBASE,
respectively. While 113 (81%) papers had records in both
MEDLINE and EMBASE, 6 (4%) papers did not have re-
cords in either database. There was no statistically sig-
nificant difference between MEDLINE and EMBASE in
the proportion of available records (p = 0.078). Table 1
provides an overview of the frequency and proportion of
records in MEDLINE and EMBASE.
Of the 113 papers that had records in both MEDLINE
and EMBASE, 13 (12%) and 12 (11%) papers were
assigned an adverse event-related indexing term in
MEDLINE and EMBASE, respectively. Only 3 (3%) pa-
pers had adverse event-related indexing terms assigned
to them in both databases, while 91 (81%) papers were
not assigned an adverse event-related indexing term in
either database. There was no difference between
MEDLINE and EMBASE in the proportion of records
being assigned an adverse event-related indexing term
(p = 1.000). Table 2 provides an overview of the fre-
quency and proportion of records that were assigned
one or more adverse event-related indexing terms.
Table 1 Frequency and proportion of available papers (n = 140)
with records in MEDLINE and EMBASE
Database Number of papers Proportion of available papers (95% CI)
MEDLINE 128 91% (86–95%)
EMBASE 119 85% (78–90%)
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Of the total pool of 140 papers, only 27 (19%) of pa-
pers mentioned adverse event-related terms in the title
or abstract. See Table 3 for a detailed overview of the
frequency of adverse event terms used in titles or ab-
stracts, as well as in MEDLINE and EMBASE records.
Discussion
The objective of this study was to investigate the com-
pleteness of indexing of adverse events in RCTs involv-
ing SMT in the MEDLINE and EMBASE databases. To
the authors’ best knowledge, this is the first review of its
kind in the SMT literature. Our results show that while
there was effective indexing of the manuscripts in the
databases, which is consistent with the existing literature
[17, 18], there was inadequate allocation of adverse event
indexing terms in each database. Specifically, that 81% of
papers did not have an adverse event-related indexing
term assigned to them is unacceptable.
There are a number of reasons for this short-coming.
Firstly, there may have been a failure of authors to cap-
ture and report on adverse events during the RCT.
Well-designed RCTs are the gold standard for investigat-
ing the efficacy of healthcare interventions and ultim-
ately provide the most reliable results [28, 29]. This
outcome is only achieved when there are adequate data
collection and reporting processes for both the beneficial
and harmful effects of an intervention. [30]. Neglecting
to collect and report on adverse events is a failure to ad-
equately investigate an intervention. Secondly, if adverse
events data were collected, they may not have been
adequately or appropriately reported. Examples of inad-
equate reporting include failure to fully report the nature
and timing of events or the number of interventions
(manipulations) provided in a trial which subsequently
precludes calculation of the incidence rate for an event.
Inappropriate reporting includes omitting the results
from the article abstract. After the title, the abstract is
the second most read section of a scientific paper [31].
Our analysis shows that reporting of adverse events as-
sociated with SMT in RCTs is inadequate and that very
few authors include this information in the abstract. Al-
though indexing terms are allocated by trained indexers
with a biomedical background and are based on the full-
text content of an article, reporting on adverse events
data in a key position such as the abstract will undoubt-
edly make the assignment of indexing terms less difficult
for database curators [16].
The inadequate reporting of adverse events is not
unique to manual therapy. A review of seven different
medical disciplines concluded that there was both a fail-
ure to distinguish between the severity of adverse events
and that the overall reporting of events was inadequate
[32], while others have highlighted the heterogeneity in
the reporting of adverse events [33]. An evaluation of
safety reporting in 15 RCTs involving complementary
and alternative medicine reported inadequate reporting
and emphasized that pooling of adverse events data was
compromised as a result [34].
Finally, it is possible that due to a lack of standardized
definitions and reporting tools, there may be confusion
amongst authors as to what exactly constitutes an ad-
verse event. What may be considered a mild adverse
event (e.g., transient muscle soreness following a ma-
nipulation) by one author could be considered to be a
normal effect of treatment by another and therefore not
reported [4, 5]. Despite this, as discussed previously, the
Table 2 Frequency and proportion of papers with records in
both MEDLINE and EMBASE (n = 113) that were assigned one
or more adverse event-related indexing term
Database Number of papers Proportion of available papers (95% CI)
MEDLINE 13 12% (6–19%)
EMBASE 12 11% (6–18%)
Table 3 Frequency of adverse event-related terms used in titles or abstracts, MEDLINE records, and EMBASE records
Title or abstract MEDLINE EMBASE
Adverse events (n = 14) Modalitya/adverse effects (n = 16) [Side Effect] (n = 5)
Side effects (n = 6) Symptoma/complications (n = 1) [Adverse Drug Reaction] (n = 6)
Adverse reactions (n = 4) Risk Assessment (n = 2) Symptoma/si [Side Effect] (n = 4)
Adverse effects (n = 3) Risk Factors (n = 1) Symptoma/ae [Adverse Drug Reaction] (n = 2)
Harm (n = 1) Symptoma/co [Complication] (n = 48)
Unpleasant reaction (n = 1) Drug effect (n = 1)
Discomfort (n = 1)
Sore (n = 1)
Serious complication (n = 1)
Side effects (n = 6)
Adverse effects (n = 3)
aAny specifically named modality (e.g., spinal manipulative therapy) or symptom (e.g., neck pain)
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CONSORT guidelines [13] provide authors with a clear
scaffold with which to report adverse events and as such,
there is no excuse for poor reporting in RCTs. Compre-
hensive reporting of adverse events associated with SMT
in RCTs that follow the CONSORT guidelines would no
doubt facilitate adequate indexing of the manuscript in
databases. Furthermore, some of the responsibility for
the current inadequate level of adverse events reporting
also resides with journal editors. Although many of the
articles in this analysis were published in journals pur-
portedly following the International Committee of Med-
ical Journal Editors (ICJME) recommendations, [35, 36]
in addition to those endorsing the CONSORT statement
[13], there remains a failure of authors to adequately re-
port both the beneficial and harmful effects of an inter-
vention. To address this shortcoming, we advocate that
journal editors ensure authors comply with CONSORT
guidelines. One way to achieve this could be requesting
that authors append a completed CONSORT checklist
to their submission in addition to instructing peer re-
viewers to check that all items on the checklist are ad-
equately addressed. Furthermore, journal editors need to
ensure that authors are instructed to revise manuscripts
with inadequate reporting of adverse events.
Adverse event-related indexing terms were reported in
approximately 10% of all articles. There was considerable
heterogeneity among the indexing terms used as seen in
Table 3. In the MEDLINE database, the majority of
indexing terms reported ‘Modality*/adverse effects’ while
terms indicating ‘risk’ were also used. In the EMBASE
database, a large number of the adverse events reported
on the effects of drugs rather than SMT but were in-
cluded in this analysis for completeness. Terms indicat-
ing ‘side effect’ were also commonly used.
The text words used to describe adverse events in the
titles and abstracts of the articles also displayed marked
heterogeneity. While we found that the term ‘adverse
event’ was most frequently used, words such as ‘side-
effects’, ‘adverse reactions’ and ‘effects’, ‘harms’ and
‘unpleasant reaction’ were also used. Notably, the defi-
nitions advocated by the CONSORT guidelines recom-
mend the use of the term ‘harms’ which was only
reported once in our analysis.
A ‘harm’ is defined as the totality of possible adverse
consequences of an intervention or therapy; it is the
direct opposite of benefit, against which it is being com-
pared [15]. Thus, its use is recommended over terms
such as ‘side effect’ which have traditionally been used to
describe unintended drug effects and do not delineate
between harmful or beneficial effects. In addition to this,
it has the potential to understate the importance of
harms as ‘side’ may be perceived as denoting secondary
importance [37]. Furthermore, the term ‘side effect’ may
be misleading as it suggests causality i.e., the effect is
caused by the intervention being tested. In a typical
RCT it may not be possible to ascertain whether an ob-
served event is partially, entirely or not at all due to the
intervention as there may be unknown, underlying and
complicating comorbidities present. As mentioned previ-
ously, the purpose of an RCT is to collect and appropri-
ately report both beneficial and harmful effects
coinciding with the application of an intervention and to
compare these outcomes across groups. The term ‘ad-
verse event’ is therefore preferred when describing a
harmful event that occurs during a trial.
As discussed above, lack of reporting on adverse events
in the title and abstracts of reports on SMT obstructs the
allocation of appropriate indexing terms, thus impeding
research into adverse events in this area. Without infor-
mation concerning the risks of SMT, consumers and prac-
titioners alike do not have access to the information
necessary to accurately inform a balanced risk-benefit ana-
lysis of this type of intervention [38, 39].
We advocate for a standardized definition for all clas-
sifications of adverse events and subsequent reporting
tools specific to SMT. Furthermore, we recommend that
journal editors enforce use of the CONSORT statement
and thus adverse events reporting in the abstract. This
would facilitate consistency of adverse event-related
indexing terms in the future.
Limitations
There are several limitations to this secondary analysis.
Firstly, electronic searches for the original dataset were
performed in two databases only (PEDro and Cochrane
CENTRAL), which may have resulted in the omission of
eligible articles found in other databases. However, we
believe this is unlikely as both PEDro and Cochrane
CENTRAL index RCTs published in all journals and
Cochrane CENTRAL also indexes the grey literature. In
addition to this, it has been reported that PEDro and
Cochrane CENTRAL indexed 99% and 98% of 281
RCTs, respectively, when compared to PubMed,
EMBASE and CINAHL [17]. Furthermore, our results
concerning the indexing of the articles were similar to
those results already published [17, 18].
Secondly, the review only included articles published
in English. It has been reported that journals published
in English are more likely to report positive findings
[40]. It is uncertain what effect this language-bias may
have had, but it is unlikely that the results would have
been altered in any meaningful way as only 3 articles
were excluded for this reason [41, 42].
Thirdly, we do not believe there is sufficient evidence
to warrant an analysis of whether the indexing of ad-
verse events associated with SMT in RCT has changed
over time. It is possible that there has been an improve-
ment in indexing resulting from the introduction of the
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CONSORT guidelines [43] and widespread acceptance
of the ICMJE recommendations [36]. However, we do
not consider this a major limitation as the paucity of ad-
equate indexing outweighs any improvements which
may have occurred.
Finally, for the sake of completeness, we included all
indexing terms and text words indicating adverse events
associated with RCTs, rather than focusing only on those
related to SMT. This inclusion may have resulted in
non-specific reporting of adverse events-related indexing
terms which may have bolstered our interpretation of
the appropriateness of such indexing.
Conclusions
Despite effective indexing of RCTs involving SMT in the
MEDLINE and EMBASE databases, there is a failure of
allocation of adverse event indexing terms in both data-
bases. This is likely due to a number of factors, specific-
ally – a lack of standardized nomenclature surrounding
adverse events associated with SMT, the inadequate
reporting of adverse events in RCTs that involve SMT
and a lack of understanding on behalf of authors about
the mechanics of manuscript indexing in databases. We
recommend the development of standardized definitions
for adverse events associated with SMT, in addition to
the development of standardized adverse events report-
ing tools which will in turn improve the reporting of
adverse events by authors. Adequate reporting of ad-
verse events associated with SMT will facilitate accurate
indexing of these types of manuscripts in the databases.
Finally, we suggest that education of manual therapy re-
searchers and authors concerning the mechanics of
manuscript indexing in databases be prioritized.
Appendix 1
Cochrane CENTRAL search string
#1 “spine”:ti, ab, kw or “spinal”:ti, ab, kw
#2 “manip*”
#3 MeSH descriptor: [Musculoskeletal, Manipulations]
explode all trees
#4 MeSH descriptor: [Manipulation, Spinal] explode
all trees
#5 MeSH descriptor: [Manipulation, Chiropractic]
explode all trees




#9 #1 and #2
#10 #3 or #4 or #5 or #6 or #7 or #8 or #9
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